Marker Therapeutics Inc. (NASDAQ: MRKR) is 19.31% higher on its value in year-to-date trading and has touched a low of $1.32 and a high of $3.39 in the current 52-week trading range. The MRKR stock was last observed hovering at around $1.47 in the last trading session, with the day’s gains setting it 0.26% off its average median price target of $7.00 for the next 12 months. It is also 78.38% off the consensus price target high of $8.00 offered by 2 analysts, but current levels are 71.17% higher than the price target low of $6.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $1.73, the stock is 10.72% and 12.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.79 million and changing 17.69% at the moment leaves the stock -6.46% off its SMA200. MRKR registered -39.93% loss for a year compared to 6-month loss of -11.73%. The firm has a 50-day simple moving average (SMA 50) of $1.5800 and a 200-day simple moving average (SMA200) of $1.7072.
The stock witnessed a 8.81% gain in the last 1 month and extending the period to 3 months gives it a 12.70%, and is 9.49% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.19% over the week and 9.31% over the month.
Marker Therapeutics Inc. (MRKR) has around 28 employees, a market worth around $87.09M and $0.70M in sales. Distance from 52-week low is 31.06% and -48.97% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.10%).
Marker Therapeutics Inc. (MRKR) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Marker Therapeutics Inc. (MRKR) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Marker Therapeutics Inc. is expected to release its quarterly report on 05/18/2021 and quarterly earnings per share for the current quarter are estimated at -$0.16.The EPS is expected to grow by 93.90% this year, but quarterly earnings will post 125.40% year-over-year.
Marker Therapeutics Inc. (MRKR) Top Institutional Holders
87 institutions hold shares in Marker Therapeutics Inc. (MRKR), with 14.35M shares held by insiders accounting for 29.88% while institutional investors hold 42.54% of the company’s shares. The shares outstanding are 46.57M, and float is at 33.67M with Short Float at 10.20%. Institutions hold 29.82% of the Float.
The top institutional shareholder in the company is NEA Management Company, LLC with over 5.0 million shares valued at $7.5 million. The investor’s holdings represent 10.41% of the MRKR Shares outstanding. As of Sep 29, 2020, the second largest holder is Aisling Capital Management LP with 2.0 million shares valued at $3.0 million to account for 4.16% of the shares outstanding. The other top investors are Blackrock Inc. which holds 1.96 million shares representing 4.09% and valued at over $2.94 million, while Vanguard Group, Inc. (The) holds 3.03% of the shares totaling 1.46 million with a market value of $2.19 million.